Ascendis Pharma A/S (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Ascendis Pharma A/S - ADR: Is Infosys Ltd. worth buying?
Item: Ascendis Pharma A/S - ADR
Rating: 1.79466675
Author: Trendlyne DVM scores

about

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, ...

225.60 -5.10 (-2.21%)

420.0K

XNAS Volume

XNAS 25 Sep, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

25.7 / 100

Technically Neutral

46.1 / 100

309

1Yr Price target upside is 37%

20 analysts

Ascendis Pharma A/S (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..